GeneDx Holdings Corp. is a genomics company. The Company operates, through its subsidiary, GeneDx, LLC, which is focused on exome and genome tests that translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. It operates through GeneDx segment, which primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. Exome sequencing test options include XomeDx, XomeDx Plus, and XomeDxXpress. GeneDx genome sequencing evaluates the protein-coding and non-coding regions of an individual’s nuclear genome. GeneDx genome sequencing test options include GenomeSeqDx and GenomeXpress. It offers a menu of targeted variant testing options to meet the needs of families and healthcare providers. Its subsidiary, Fabric Genomics, Inc., specializes in artificial intelligence-powered genomic interpretation.
회사 코드WGS
회사 이름GeneDx Holdings Corp
상장일Sep 04, 2020
설립일2020
CEOMs. Katherine A. Stueland
직원 수1000
유형Ordinary Share
회계 연도 종료Sep 04
주소333 Ludlow Street
도시STAMFORD
증권 거래소NASDAQ Global Select Consolidated
국가United States of America
우편 번호06902
전화18887291206
웹사이트https://sema4.com/
회사 코드WGS
상장일Sep 04, 2020
설립일2020
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음